1 hour ago
AstraZeneca (AZN) Stock Climbs After Strong Q2 Earnings Beat Analyst Expectations
AstraZeneca (AZN) stock gains 1.6% after reporting Q2 core EPS of $2.63, exceeding forecasts. Oncology sales climb 15% despite recent trial setbacks.
The post AstraZeneca (AZN) Stock Climbs After Strong Q2 Earnings Beat Analyst Expectations appeared first on Blockonomi.
Source: Blockonomi →Related News
- 43 minutes ago
Nestlé (NSRGF) Shares Decline as BofA Cuts Rating on Pet Food Market Share Losse...
- 51 minutes ago
Gold Surges Past $4,095 as Middle East Ceasefire Triggers Oil Sell-Off
- 58 minutes ago
European Markets Surge on U.S.-Iran Ceasefire as Crude Oil Plunges
- 1 hour ago
Synopsys (SNPS) Stock Surges on AI-Powered Chip Design Partnership with NVIDIA
- 1 hour ago
Ark Invest’s Cathie Wood Scoops Up $21M in SpaceX Shares During Market Pullback